15 May 2010

46th DIA Annual Meeting - Washington DC, June 2010

The Medicines Evaluation Unit will be in attendance at the 46^th DIA Annual Meeting at the Walter E. Washington Convention Center - Washington, DC, USA from 13^th. to 16^th. June 2010.  Please come and visit us on booth 116.

4th May  2010

World Asthma Day

Wythenshawe Hospital Outpatients entrance - 11am-3pm

This event, hosted by the Medicines Evaluation Unit (MEU), is to promote good asthma control and increase public awareness.  Come along, enjoy some refreshments, and receive free asthma education and support from trained MEU staff.

4 March 2010

DIA Euro Meeting, Monaco, March 2010

The Medicines Evaluation Unit will be exhibiting at the DIA Euro Meeting in Monaco on  8th-10th March 2010 - please come and visit us on stand 53.

 21 October 2009

MEU gain award for the Clinical Research Team of the Year, 2009.

A team of researchers from the MEU were presented with the GCPj award for "Clinical Research Team of the Year" at a ceremony which took place on 20th October 2009 at the Merchant Taylors  Hall in London.

Above, left to right:
Front Row,  Liz Batty, Janice Feast, Deilwen Baldwin
Second Row: Janet Holden, Kirstie Lea, Kate Aherne,  Ruth Trotter, Helen Francis
Third Row: Gary Parkinson, Alan Bell, Joeleen McKenna , Sarah Percy
Rear Row: John Goddard, Phil Mitchel, Dave Singh, David Rogers.

Above: Deil Baldwin (centre) with the award.

Team members (left to right): Gary Parkinson, Joeleen McKenna, John Goddard, Alan Bell, Phil Mitchel.

16th September 2009

MEU Staff Nominated for the 2009 Clinical Research Excellence Awards.

The following have been short listed for awards to be presented at the GCPj (Good Clinical Practice Journal) 2009 Clinical Research Excellence Awards on 20th October
2009 at the Merchant Taylor’s Hall, London: 

See www.gcpjawards.com for full details.

6th July 2009

The Medicines Evaluation Unit is granted MHRA Phase 1 accreditation.

The MEU are proud to announce that we have been awarded the Medicines and Healthcare products Regulatory Agency (MHRA) Standard and Supplementary Phase I Accreditation. This award demonstrates the high safety and quality standards we apply to the performance of clinical trials here at the MEU.

The accreditation is a voluntary process whereby the MEU’s facility, practices, staffing and experience are inspected by the MHRA, the UK government agency responsible for ensuring that medicines and medical devices work, and are acceptably safe.

This accreditation is the highest award for clinical trials in Europe and allows the MEU to conduct all phases of clinical trials including FTIH trials that require a review of risk factors by the Expert Advisory Group (EAG).

“This award is a well deserved accolade and places the MEU in the top ten of Clinical Research Units based on a hospital site in the UK” David Rogers, Director of Operations.